Skin cancer prevention–Recent advances and unmet challenges
M Mortaja, S Demehri - Cancer Letters, 2023 - Elsevier
Cutaneous squamous cell carcinoma (cSCC) is the second most common malignancy in the
world. Among many identified risk factors, immunosuppression is a major factor that …
world. Among many identified risk factors, immunosuppression is a major factor that …
[HTML][HTML] Pharmacological agents used in the prevention and treatment of actinic keratosis: a review
D Arcuri, B Ramchatesingh, F Lagacé… - International Journal of …, 2023 - mdpi.com
Actinic keratosis (AK) is among the most commonly diagnosed skin diseases with potentially
life-threatening repercussions if left untreated. Usage of pharmacologic agents represents …
life-threatening repercussions if left untreated. Usage of pharmacologic agents represents …
[HTML][HTML] European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment–Update 2023
AJ Stratigos, C Garbe, C Dessinioti, C Lebbe… - European Journal of …, 2023 - Elsevier
In order to update recommendations on treatment, supportive care, education, and follow-up
of patients with invasive cutaneous squamous cell carcinoma (cSCC), a multidisciplinary …
of patients with invasive cutaneous squamous cell carcinoma (cSCC), a multidisciplinary …
[HTML][HTML] Recent Advances in Clinical Research for Skin Cancer Chemoprevention
R Tow, S Hanoun, B Andresen, A Shahid, J Wang… - Cancers, 2023 - mdpi.com
Simple Summary Skin cancer is the most common cancer type in the United States and the
world. Both non-melanoma and melanoma skin cancer show a clear association with …
world. Both non-melanoma and melanoma skin cancer show a clear association with …
[HTML][HTML] Interventions after first post-transplant cutaneous squamous cell carcinoma: a proposed decision framework
MJ Bottomley, PR Massey… - Transplant …, 2022 - frontierspartnerships.org
Cutaneous squamous cell carcinoma (CSCC) is a major cause of morbidity and mortality
after organ transplant. Many patients subsequently develop multiple CSCC following a first …
after organ transplant. Many patients subsequently develop multiple CSCC following a first …
[HTML][HTML] miR-184 represses β-catenin and behaves as a skin tumor suppressor
L Turovsky, G Kheshaiboun, G Yassen, S Nagosa… - Cell Death & …, 2024 - nature.com
Abstract miR-184-knockout mice display perturbed epidermal stem cell differentiation.
However, the potential role of miR-184 in skin pathology is unclear. Here, we report that miR …
However, the potential role of miR-184 in skin pathology is unclear. Here, we report that miR …
[HTML][HTML] Accelerating patient recruitment using social media: Early adopter experience from a good clinical practice-monitored randomized controlled phase I/IIa …
VK Ortner, JR Zibert, O Budnik, I Manole… - Contemporary Clinical …, 2024 - Elsevier
Background Patient recruitment is a major cause of delays in randomized controlled trials
(RCT). Online recruitment is evolving into an alternative to conventional in-clinic recruitment …
(RCT). Online recruitment is evolving into an alternative to conventional in-clinic recruitment …
Efficacy and safety of tirbanibulin 1% ointment in actinic keratoses: Data from two phase‐III trials and the real‐life clinical practice presented at the European Academy …
G Pellacani, T Schlesinger, N Bhatia… - Journal of the …, 2024 - Wiley Online Library
Abstract Background The 31st European Academy of Dermatology and Venereology
(EADV) Congress took place between 7th and 10th of September 2022 in Milan, Italy …
(EADV) Congress took place between 7th and 10th of September 2022 in Milan, Italy …
European consensus‐based interdisciplinary guideline for diagnosis, treatment and prevention of actinic keratoses, epithelial UV‐induced dysplasia and field …
L Kandolf, K Peris, J Malvehy, K Mosterd… - Journal of the …, 2024 - Wiley Online Library
A collaboration of multidisciplinary experts from the European Association of Dermato‐
Oncology, the European Dermatology Forum, the European Academy of Dermatology and …
Oncology, the European Dermatology Forum, the European Academy of Dermatology and …
[HTML][HTML] The “Personalising Actinic Keratosis Treatment for Immunocompromised Patients”(IM-PAKT) Project: An Expert Panel Opinion
RM Szeimies, C Ulrich, C Ferrándiz-Pulido… - Dermatology and …, 2024 - Springer
Actinic keratosis (AK) is an intraepithelial condition characterized by the development of
scaly, erythematous lesions after repeated exposure to ultraviolet radiation. Significant …
scaly, erythematous lesions after repeated exposure to ultraviolet radiation. Significant …